Filing Flows › HCW Biologics (HCWB) › Q1 2025
HCW Biologics (HCWB) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 15, 2025
HCW Biologics (HCWB) reported revenue of $5K for the first quarter 2025 (Q1 2025), -100% from a year earlier and -99% from the quarter before.
HCW Biologics, Q1 2025: revenue $5K (-100% year over year), net loss $2.2M, operating cash flow −$3.5M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5K | -99% | -100% |
| Operating profit | −$2.0M | — | — |
| Net earnings | −$2.2M | — | — |
| Operating cash flow | −$3.5M | — | — |
What changed
Revenue was $5K in Q1 2025, down 100% year over year and down 99% from the previous quarter.
Gross margin was 20.0%, down 34.6 points from a year earlier. Operating costs exceeded revenue by $2.0M, an operating margin of -38811.5%. Operating expenses fell 76% while revenue fell 100%. The quarter ended with a net loss of $2.2M, narrower than the previous quarter's $3.4M loss.
Operating cash flow was −$3.5M. Non-cash charges added back $419K of depreciation and amortization and $276K of share-based compensation. Working capital and other items used $2.0M.
Questions
What was HCW Biologics' revenue in the first quarter 2025?
HCW Biologics (HCWB) reported revenue of $5K for the first quarter 2025 (Q1 2025), -100% from a year earlier and -99% from the quarter before.
Source: HCW Biologics 10-Q on SEC EDGAR.